Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nicole Hadas Insider Profile
4 Followers
Nicole Hadas, SVP, CLO at Akebia Therapeutics, holds 663.26K shares in Akebia Therapeutics (Ticker: AKBA). Most recently, Nicole Hadas Sold $5,974 shares of Akebia Therapeutics on Mar 01, 2024 for an estimated value of 9.44K.
Profitable Transactions
6 out of 11 Profitable Transactions
Average Return
0.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
SVP, CLO
Roles that Nicole Hadas holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Apr 01, 2021 - Apr 01, 2022
Return:+79.90%
The most profitable trade made by Nicole Hadas
Nicole Hadas's Trading History
List of latest transactions for each holding click on a transaction to see Nicole Hadas's performance on stock
You May Also Like
Nicole Hadas insider profile FAQ
What is the percentage of profitable transactions made by Nicole Hadas?
The percentage of profitable transactions made by Nicole Hadas is 55%.
What is the average return per transaction made by Nicole Hadas?
The average return per transaction made by Nicole Hadas is 0.00%.
What stocks does Nicole Hadas hold?
Nicole Hadas holds: AKBA stocks.
What was Nicole Hadas’s latest transaction?
Nicole Hadas latest transaction was an Informative Sell of $9.44K.
What was Nicole Hadas's most profitable transaction?
Nicole Hadas’s most profitable transaction was an Informative Sell of AKBA stock on April 1, 2021. The return on the trade was 79.90%.
What is Nicole Hadas's role in Akebia Therapeutics?
Nicole Hadas's role in Akebia Therapeutics is SVP, CLO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.